Cargando…

Assessing the quality of life in age-related macular degeneration patients: A cross-sectional study in Kazakhstan

AIM: The goal of this study was to assess Vision-Related Quality of Life (VRQoL) in patients with Age-Related Macular Degeneration (AMD) and identify its significant predictors. METHODS: 458 AMD patients from four eye clinics in three major cities of Kazakhstan were recruited for this study. Data we...

Descripción completa

Detalles Bibliográficos
Autores principales: Ismayilova, Inara, Turdaliyeva, Botagoz, Aldasheva, Neilya, Veselovskaya, Natalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828926/
https://www.ncbi.nlm.nih.gov/pubmed/36533748
http://dx.doi.org/10.23750/abm.v93i6.13580
_version_ 1784867369884057600
author Ismayilova, Inara
Turdaliyeva, Botagoz
Aldasheva, Neilya
Veselovskaya, Natalia
author_facet Ismayilova, Inara
Turdaliyeva, Botagoz
Aldasheva, Neilya
Veselovskaya, Natalia
author_sort Ismayilova, Inara
collection PubMed
description AIM: The goal of this study was to assess Vision-Related Quality of Life (VRQoL) in patients with Age-Related Macular Degeneration (AMD) and identify its significant predictors. METHODS: 458 AMD patients from four eye clinics in three major cities of Kazakhstan were recruited for this study. Data were collected using a structured questionnaire on sociodemographic and visual information and the National Eye Institute-Visual Function Questionnaire-39 (NEI-VFQ-39). RESULTS: The study sample included 181 male patients who were 64.9 years on average (SD±8.4), and 277 female patients who were 68.7 years on average (SD±10.7). The majority of patients had stage 2 (43.7%) or stage 3 (40.2%) AMD according to the Age-Related Eye Disease Study (AREDS) classification. The mean (SD) NEI-VFQ-39 total score was 58.0 (23.8), range (9.8 - 100). The multiple linear regression model showed that the VRQoL of AMD patients correlated with the AMD stage according to the AREDS classification, age of the patients, visual acuity, number of years since the AMD diagnosis, and the city of residence. CONCLUSIONS: AMD causes severe vision impairment and daily functioning problems, reducing the quality of life of patients. To diagnose and treat degenerative eye disorders at an early stage, it is essential to inform patients about regular ophthalmological checkups to diagnose and treat degenerative eye disorders at an early stage. (www.actabiomedica.it)
format Online
Article
Text
id pubmed-9828926
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-98289262023-01-19 Assessing the quality of life in age-related macular degeneration patients: A cross-sectional study in Kazakhstan Ismayilova, Inara Turdaliyeva, Botagoz Aldasheva, Neilya Veselovskaya, Natalia Acta Biomed Original Article AIM: The goal of this study was to assess Vision-Related Quality of Life (VRQoL) in patients with Age-Related Macular Degeneration (AMD) and identify its significant predictors. METHODS: 458 AMD patients from four eye clinics in three major cities of Kazakhstan were recruited for this study. Data were collected using a structured questionnaire on sociodemographic and visual information and the National Eye Institute-Visual Function Questionnaire-39 (NEI-VFQ-39). RESULTS: The study sample included 181 male patients who were 64.9 years on average (SD±8.4), and 277 female patients who were 68.7 years on average (SD±10.7). The majority of patients had stage 2 (43.7%) or stage 3 (40.2%) AMD according to the Age-Related Eye Disease Study (AREDS) classification. The mean (SD) NEI-VFQ-39 total score was 58.0 (23.8), range (9.8 - 100). The multiple linear regression model showed that the VRQoL of AMD patients correlated with the AMD stage according to the AREDS classification, age of the patients, visual acuity, number of years since the AMD diagnosis, and the city of residence. CONCLUSIONS: AMD causes severe vision impairment and daily functioning problems, reducing the quality of life of patients. To diagnose and treat degenerative eye disorders at an early stage, it is essential to inform patients about regular ophthalmological checkups to diagnose and treat degenerative eye disorders at an early stage. (www.actabiomedica.it) Mattioli 1885 2022 2022-12-16 /pmc/articles/PMC9828926/ /pubmed/36533748 http://dx.doi.org/10.23750/abm.v93i6.13580 Text en Copyright: © 2022 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA https://creativecommons.org/licenses/by-nc-sa/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Original Article
Ismayilova, Inara
Turdaliyeva, Botagoz
Aldasheva, Neilya
Veselovskaya, Natalia
Assessing the quality of life in age-related macular degeneration patients: A cross-sectional study in Kazakhstan
title Assessing the quality of life in age-related macular degeneration patients: A cross-sectional study in Kazakhstan
title_full Assessing the quality of life in age-related macular degeneration patients: A cross-sectional study in Kazakhstan
title_fullStr Assessing the quality of life in age-related macular degeneration patients: A cross-sectional study in Kazakhstan
title_full_unstemmed Assessing the quality of life in age-related macular degeneration patients: A cross-sectional study in Kazakhstan
title_short Assessing the quality of life in age-related macular degeneration patients: A cross-sectional study in Kazakhstan
title_sort assessing the quality of life in age-related macular degeneration patients: a cross-sectional study in kazakhstan
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828926/
https://www.ncbi.nlm.nih.gov/pubmed/36533748
http://dx.doi.org/10.23750/abm.v93i6.13580
work_keys_str_mv AT ismayilovainara assessingthequalityoflifeinagerelatedmaculardegenerationpatientsacrosssectionalstudyinkazakhstan
AT turdaliyevabotagoz assessingthequalityoflifeinagerelatedmaculardegenerationpatientsacrosssectionalstudyinkazakhstan
AT aldashevaneilya assessingthequalityoflifeinagerelatedmaculardegenerationpatientsacrosssectionalstudyinkazakhstan
AT veselovskayanatalia assessingthequalityoflifeinagerelatedmaculardegenerationpatientsacrosssectionalstudyinkazakhstan